193 related articles for article (PubMed ID: 6652878)
1. Salutary effects of anisodamine in murine traumatic shock.
Hock CE; Su JY; Lefer AM
Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of anisodamine in hemorrhagic shock.
Su J; Hock CE; Lefer AM
Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
[TBL] [Abstract][Full Text] [Related]
5. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
Karasawa A; Rochester JA; Lefer AM
Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
[TBL] [Abstract][Full Text] [Related]
6. Protective actions of nafazatrom in traumatic shock.
Lefer AM; Messenger M
Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
[TBL] [Abstract][Full Text] [Related]
7. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
Hock CE; Lefer DJ; Lefer AM
Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
[TBL] [Abstract][Full Text] [Related]
8. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
Bitterman H; Smith BA; Lefer AM
Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
[TBL] [Abstract][Full Text] [Related]
9. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
Bitterman H; Smith BA; Lefer AM
Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
Aoki N; Johnson G; Siegfried MR; Lefer AM
Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of two leukotriene antagonists in rat traumatic shock.
Levitt MA; Lefer AM
Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
[TBL] [Abstract][Full Text] [Related]
12. Protective actions of aprotinin in acute traumatic shock.
Araki H; Lefer AM
Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):316-23. PubMed ID: 316692
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
Levitt MA; Lefer AM
Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
[TBL] [Abstract][Full Text] [Related]
14. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
Karasawa A; Rochester JA; Lefer AM
Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
[TBL] [Abstract][Full Text] [Related]
15. Beneficial actions of prostacyclin in traumatic shock.
Lefer AM; Sollott SL; Galvin MJ
Prostaglandins; 1979 May; 17(5):761-7. PubMed ID: 386429
[TBL] [Abstract][Full Text] [Related]
16. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
Levitt MA; Lefer AM
Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of a novel thromboxane analog in lethal traumatic shock.
Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL
Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of a neutral protease inhibitor in traumatic shock.
Hock CE; Lefer AM
Pharmacol Res Commun; 1985 Mar; 17(3):217-26. PubMed ID: 4011646
[TBL] [Abstract][Full Text] [Related]
19. Cell protection mechanism of antishock action of anisodamine.
Su JY
Chin Med J (Engl); 1992 Dec; 105(12):976-9. PubMed ID: 1299554
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of oligotide, a novel oligodeoxyribonucleotide, in murine traumatic shock.
Skurk C; Nuss C; Lefer AM
Shock; 1995 Jan; 3(1):13-20. PubMed ID: 7531603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
